Partners & Collaborators

EntroGen, Inc and CHLA are currently collaborating on the development of a genome-based diagnostic biomarker for Ewing's Sarcoma family of tumors.

Founded in 1901, Childrens Hospital Los Angeles has been treating the most seriously ill and injured children in Los Angeles for more than a century, and it is acknowledged throughout the United States and around the world for its leadership in pediatric and adolescent health. Childrens Hospital is one of America’s premier teaching hospitals, affiliated with the Keck School of Medicine of the University of Southern California since 1932. The Saban Research Institute of Childrens Hospital Los Angeles is among the largest and most productive pediatric research facilities in the United States.

Since 1990, U.S. News & World Report and its panel of board-certified pediatricians have named Childrens Hospital Los Angeles one of the top pediatric facilities in the nation. Childrens Hospital Los Angeles is one of only 10 children’s hospitals in the nation – and the only children’s hospital on the West Coast – ranked in all 10 pediatric specialties in the U.S. News & World Report rankings and named to the magazine’s “Honor Roll” of children’s hospitals.

Childrens Hospital Los Angeles also is one of eight children’s hospitals in the nation to receive the “Top Hospital” designation from The Leapfrog Group. And Childrens Hospital Los Angeles is one of only three pediatric medical centers in the nation to receive both honors – “Top Hospital” from Leapfrog and the “Honor Roll” from U.S. News & World Report.

Learn more about CHLA at www.chla.org.

CML is a clinical diagnostic laboratory that helps with the validation of EntroGen, Inc's genotyping and mutation analysis assays.